AMC Theatres
AMC
$2.68
-5.96%
AMC Entertainment Holdings, Inc. is the world's largest theatrical exhibition company, operating over 900 theaters primarily in the U.S. and Europe, offering amenities like recliners, dine-in theaters, and premium large-format screens. As a dominant player in the cinema industry, AMC has leveraged its scale and premium offerings to differentiate itself, but it remains highly sensitive to box office cycles and streaming competition. The current investor narrative centers on a post-pandemic recovery in attendance, yet persistent concerns over massive share dilution—highlighted by a recent $200 million equity offering—and structural cash flow challenges continue to weigh on sentiment, even as summer box office successes provide temporary boosts.…
AMC
AMC Theatres
$2.68
Related headlines
Investment Opinion: Should I buy AMC Today?
Rating: Hold. AMC is a speculative hold, not a buy, given the high dilution risk and uncertain path to profitability. The consensus recommendation is 'hold' with an average target of $2.72, implying a slight downside, which aligns with our cautious stance. The thesis is that AMC's revenue recovery and cheap valuation offer upside, but the persistent dilution and negative cash flow cap the potential.
Sign up to view all
AMC 12-Month Price Forecast
The AI assessment is neutral with medium confidence. AMC's revenue growth and cheap valuation are positive, but the persistent losses, dilution, and balance sheet fragility create significant downside risk. The stock is likely to trade in a range, with the outcome depending on box office trends and capital management. An upgrade to bullish would require evidence of sustainable profitability and reduced dilution, while a downgrade to bearish would be triggered by another equity offering or a sharp decline in revenue. The current risk-reward is balanced, making a neutral stance appropriate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AMC Theatres's 12-month outlook, with a consensus price target around $2.72 and implied upside of +1.4% versus the current price.
Average Target
$2.72
0 analysts
Implied Upside
+1.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$2 - $4
Analyst target range
Analyst coverage is limited to 6 analysts, with a consensus recommendation of 'hold' and a mean rating of 2.71 (where 1 is strong buy and 5 is sell). The average target price is $2.72, implying a slight downside of -3.5% from the current price of $2.82. The distribution includes 1 buy, 4 holds, and 1 sell, reflecting a cautious stance. The target range spans from $1.80 (low) to $4.00 (high), with the high target suggesting a 41.8% upside, likely assuming a successful box office recovery and improved cash flow, while the low target implies a 36.2% downside, factoring in continued dilution and weak profitability. Recent ratings actions show a mix: Benchmark upgraded from Hold to Buy in May 2026, while Citigroup maintains a Sell, and Macquarie remains Neutral, indicating divergent views on the stock's trajectory.
Bulls vs Bears: AMC Investment Factors
AMC presents a classic high-risk, high-reward turnaround story. The bull case rests on accelerating revenue growth, improving margins, and a deeply discounted valuation, while the bear case is dominated by relentless dilution, persistent losses, and a fragile balance sheet. Currently, the bearish evidence is stronger given the structural cash flow challenges and the recent $200M offering that underscores the need for external capital. The most critical tension is whether AMC can achieve sustained profitability without further dilutive financing—if it does, the stock could re-rate significantly; if not, the dilution will continue to erode shareholder value. The market's current pricing at 0.165x sales suggests skepticism, but the recent momentum indicates some optimism. Ultimately, the investment debate hinges on the trajectory of box office recovery and AMC's ability to convert its scale into positive free cash flow.
Bullish
- Revenue accelerating 21.2% YoY: Q1 2026 revenue reached $1.045B, up 21.2% from $862.5M in Q1 2025, marking a strong recovery. This growth outpaces the broader industry and suggests box office momentum is translating to AMC's top line.
- Gross margin robust at 69.2%: Gross margin improved to 69.2% in Q1 2026, up from 69.6% in Q1 2025, indicating strong pricing power and cost control. This high margin provides a buffer against fixed costs and supports potential profitability as revenue scales.
- Net loss narrowing sharply: Net loss improved to -$117.1M in Q1 2026 from -$202.1M in Q1 2025, a 42% reduction. This trend, combined with positive EBITDA of $100.7M, shows the company is moving closer to breakeven.
- Stock momentum strong, up 102.9% in 6M: AMC shares have surged 102.9% over the past six months and 94.5% over three months, reflecting investor optimism about the recovery. The stock is trading near its 52-week high of $3.26, indicating strong technical momentum.
Bearish
- Massive dilution from $200M offering: AMC recently completed a $200M equity offering, increasing share count to 539.7M in Q1 2026 from 430.9M a year ago, a 25% increase. This dilution destroys shareholder value and is a primary reason for the stock's underperformance over the past year.
- Persistent unprofitability and negative FCF: Despite revenue growth, AMC remains unprofitable with a net loss of $117.1M in Q1 2026 and negative free cash flow of -$123.6M TTM. The company's high fixed costs and interest expenses ( $139.9M in Q1) continue to weigh on the bottom line.
- High leverage with negative equity: Debt-to-equity is -4.29x, reflecting negative shareholder equity, and the current ratio is 0.41x, indicating liquidity stress. This financial fragility increases bankruptcy risk if cash flows deteriorate.
- Analyst consensus is Hold with downside: The average analyst target is $2.72, implying a 3.5% downside from the current price of $2.82. With 4 holds, 1 buy, and 1 sell, the Street is cautious, and the low target of $1.80 suggests a 36.2% downside risk.
AMC Technical Analysis
AMC's stock is in a strong recovery phase, having surged 102.9% over the past six months and 94.5% over the past three months, though the one-year change is slightly negative at -2.8%. The current price of $2.82 sits near the upper end of its 52-week range, at approximately 86% of the distance from the low of $0.93 to the high of $3.26, indicating robust momentum but also potential overextension. This positioning suggests the market is pricing in a sustained turnaround, though the proximity to the 52-week high of $3.26 could invite profit-taking if momentum stalls.
Beta
2.22
2.22x market volatility
Max Drawdown
-73.2%
Largest decline past year
52-Week Range
$1-$3
Price range past year
Annual Return
-6.6%
Cumulative gain past year
| Period | AMC Return | S&P 500 |
|---|---|---|
| 1m | +41.8% | +3.6% |
| 3m | +63.4% | +5.1% |
| 6m | +91.4% | +13.8% |
| 1y | -6.6% | +22.2% |
| ytd | +66.5% | +13.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AMC Fundamental Analysis
AMC's revenue trajectory is improving, with Q1 2026 revenue of $1.045 billion, up 21.2% year-over-year, and the company has posted sequential growth from the $862.5 million in Q1 2025. However, the growth is uneven, as Q4 2025 revenue was $1.288 billion, and Q3 2025 was $1.300 billion, indicating a seasonal dip in Q1. The company remains unprofitable, with a net loss of $117.1 million in Q1 2026, though this is a significant improvement from the $202.1 million loss in Q1 2025. Gross margin is healthy at 69.2%, but operating margin is slightly negative at -0.04%, reflecting high fixed costs and interest expenses.
Quarterly Revenue
$1.0B
2026-03
Revenue YoY Growth
+21.2%
YoY Comparison
Gross Margin
69.2%
Latest Quarter
Free Cash Flow
$-123600000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AMC Overvalued?
Given AMC's negative net income, the price-to-sales (PS) ratio is the most appropriate valuation metric, currently at 0.165x, which is extremely low compared to the industry average of around 1.5x, indicating a significant discount. The EV-to-sales ratio of 1.799x provides a more comprehensive view, still below the sector's typical 2.5x. The negative PE ratios (trailing -1.27x and forward -22.56x) are not meaningful for comparison, but the forward PS ratio of 0.165x suggests the market is pricing in minimal growth expectations, which may be overly pessimistic given the recent revenue acceleration.
PE
-1.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
39.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are severe. AMC's negative free cash flow of -$123.6M TTM and net losses of -$117.1M in Q1 2026 highlight a cash burn that necessitates external financing, as evidenced by the recent $200M equity offering. The company's debt burden is substantial, with interest expenses of $139.9M in Q1 alone, and negative shareholder equity (debt-to-equity -4.29x) leaves no cushion for creditors. The current ratio of 0.41x indicates liquidity stress, meaning AMC may struggle to meet short-term obligations without additional capital raises, which would further dilute shareholders. Revenue concentration in the cyclical box office makes earnings highly volatile, as seen in the swing from a $4.7M loss in Q2 2025 to a $298.2M loss in Q3 2025, driven by film slate timing.
FAQ
The key risks are: (1) dilution from equity offerings, which has already increased shares by 25% in the past year; (2) financial risk from high debt and negative equity, with a debt-to-equity of -4.29x and interest expenses of $139.9M per quarter; (3) market risk from a high beta of 2.28, making the stock highly volatile; (4) competitive risk from streaming services, which could reduce theater attendance. The most severe risk is a liquidity crisis leading to bankruptcy, which would result in a total loss. These risks are ranked by severity, with dilution and financial fragility being the most immediate threats.
The 12-month forecast is uncertain, with a base case probability of 50% for a target range of $2.50-$3.00, aligning with the analyst average of $2.72. The bull case (25% probability) targets $3.26-$4.00, assuming strong box office recovery and improved profitability. The bear case (25% probability) targets $0.93-$1.80, if dilution and losses continue. The most likely scenario is the base case, where the stock trades sideways as the market weighs recovery against structural challenges. Key assumptions include stable interest rates and no major equity offerings.
AMC is undervalued on a price-to-sales basis, with a PS ratio of 0.165x versus the industry average of 1.5x, indicating a deep discount. However, the EV/Sales ratio of 1.799x is closer to the sector's 2.5x, suggesting that when debt is considered, the discount is less pronounced. The negative PE ratios are not meaningful due to losses. The market is pricing in minimal growth and high risk, which is justified given the company's negative equity and cash flow. Overall, AMC is fairly valued relative to its fundamentals, but the low PS ratio offers potential upside if the company can turn around.
AMC is not a good buy for most investors due to its high risk profile. The stock has a consensus 'hold' rating with an average target of $2.72, implying a slight downside from the current price of $2.82. The potential upside to the high target of $4.00 is 41.8%, but the downside to the low target of $1.80 is 36.2%, making the risk-reward unattractive. The biggest risk is dilution from equity offerings, which has already increased the share count by 25% over the past year. For speculative investors with a high risk tolerance, AMC could be a small position, but it is not a suitable core holding.
AMC is more suitable for short-term trading than long-term investing due to its high volatility and uncertain fundamentals. The stock has a beta of 2.28, meaning it moves significantly with the market, and its price has swung from $0.93 to $3.26 in the past year. The company does not pay a dividend, and its negative cash flow makes long-term value creation questionable. For long-term investors, the risk of dilution and potential bankruptcy is too high. A short-term trading approach could capitalize on momentum, but it requires active monitoring and risk management. If held long-term, a minimum horizon of 3-5 years would be needed to see if the turnaround succeeds, but the risk of permanent loss is substantial.